Study of cardiomyopathy in children
Part of Heart & circulation clinical trials.
This trial studies children with cardiomyopathy to better understand the condition. It's for children who have been diagnosed with cardiomyopathy and who do not have other major heart problems or serious issues with other organs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a child diagnosed with cardiomyopathy.
- You do not have other heart diseases like congenital heart disease or valve problems.
- You do not have serious issues with your heart, kidneys, or other major organs.
- You are not mentally unwell.
- You and your family are willing and able to follow the study instructions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses special heart imaging tests (MRI or CT scans) to look at the hearts of children with myocarditis, a condition where the heart muscle is inflamed. The goal is to better understand the inflammation and help guide treatment.
This is an observational study that follows children under 18 with cardiomyopathy caused by certain MYBPC3 gene mutations. It aims to better understand how the disease changes over time, which may help future treatments be better targeted.
This trial studies children with inherited (genetic) heart conditions that started before age 16. It may help improve how doctors identify the genetic cause and understand which families are affected.
This study is looking at people with cardiomyopathy to understand which patients are most in need of a heart transplant. By joining, you will help doctors learn more about critical cases and improve care for heart muscle disease.
This study looks at genetic (DNA) changes that may cause cardiomyopathy, a disease where the heart muscle is weakened. It may help families understand possible causes and inform future care.
This study looks at people with cardiomyopathy (or related heart muscle conditions) and those who may be at risk because of family history or genetic test results. It may help researchers better understand who is likely to develop the condition and how best to monitor or support them.
Hear when a new Pediatric Cardiomyopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.